Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Rothman Institute

Neither a doctor nor a teaching hospital

Research payments

$103,523

24 payments

Through program year 2025, Rothman Institute is reported as receiving $103,523 in research payments, across 24 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $12,016 1
2024 Research $7,500 2
2023 Research $28,331 5
2022 Research $1,670 1
2021 Research $20,373 4
2020 Research $6,450 1
2019 Research $27,183 10

Breakdown

Who paid Research payments · program years 2019–2025
  1. Encore Medical, LP $34,811 6 payments
  2. Cerapedics, Inc. $20,094 2 payments
  3. Pfizer Inc. $8,670 2 payments
  4. Lima USA, Inc. $8,340 2 payments
  5. Flexion Therapeutics, Inc. $7,950 2 payments
  6. Vericel Corporation $7,500 2 payments
  7. Avanos Medical $7,052 2 payments
  8. Stryker Corporation $4,600 1 payment
  9. Smith+Nephew, Inc. $1,740 2 payments
  10. Vertex Pharmaceuticals Incorporated $1,530 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. Prospective multicenter study to examine the influence of repairing the sub-scapularis on outcomes after reverse arthroplasty: A randomized, controlled trial $27,616 4 payments
  2. Aspire Trial $20,094 2 payments
  3. Determining the True Financial and Functional Burden of Periprosthetic Joint Infection A Prospective Study $8,670 2 payments
  4. A Randomized, Multi-Center, Prospective, Safety and Efficacy Study comparing the outcome of total reverse shoulder arthroplasty (RSA) with SMR Stemless Reverse vs SMR Reverse Shoulder System $8,340 2 payments
  5. MACI Multicenter Clinical Outcomes Registry $7,500 2 payments
  6. Prospective multicenter study to examine the influence of repairing the sub-scapularis on outcomes after reverse arthroplasty A randomized, controlled trial $7,195 2 payments
  7. Use of Cooled Radiofrequency for the treatment of Hip Pain associated with OA of the Hip compared to steroid injections $7,052 2 payments
  8. A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Patients with Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis $6,450 1 payment
  9. A Prospective, Single Blinded, Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Effictiveness of the Inspace Device for Treament of Full Thickness Massive Rotator Cuff Tears $4,600 1 payment
  10. A Post Market, Prospective, Multi-Center, Open-Label, Single Arm Clinical Evaluation of Integra Cadence TM Total Ankle System in Primary Ankle Joint Replacement $1,740 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record